Positions

Principal Investigator On

  • Assessment of Worldwide Acute Kidney Injury (AKI), Renal Angina (the “AWARE Study)  awarded by CINCINNATI CHILDREN'S HOSPITAL 2013 - 2023
  • Acute Renal Injury Sequelae in NICU Graduates (ARISING)  awarded by National Institute of Diabetes and Digestive and Kidney Diseases/NIH/DHHS 2019 - 2021
  • Private Grant  awarded by CHF SOLUTIONS 2019 - 2020
  • AKI Sample NGAL Test™ Validation Protocol  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI) 2018 - 2020
  • Aquadex FlexFlow System and Renal Support using Aquadex: A Multicenter Retrospective Study  awarded by SEATTLE CHILDREN'S RESEARCH INSTITUTE 2019 - 2020
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2016 - 2019
  • Recombinant Erythropoietin for Protection of Infant Renal Disease (REPAIReD)  awarded by SEATTLE CHILDREN'S RESEARCH INSTITUTE 2014 - 2019
  • Phase 2 Study of Selective Cytopheretic Device for the Treatment of Pediatric Patients with Acute Kidney Injury  awarded by CINCINNATI CHILDREN'S HOSPITAL 2015 - 2019
  • Private Grant  awarded by OCTAPHARMA - NEW 2016 - 2019
  • Private Grant  awarded by CYTOPHERX, INC. 2017 - 2019
  • Reduction of Nephrotoxic Medication-Associated Acute Kidney Injury in Children - NINJA  awarded by CINCINNATI CHILDREN'S HOSPITAL 2015 - 2018
  • Private Grant  awarded by OTSUKA PHARMACEUTICAL DEVELOPMENT & COMMERCIALIZATION, INC 2016 - 2017
  • The Genetic Contribution to Drug Induced Renal lnjury:The Drug Induced Renal Injury Consortium (DIRECT)  awarded by INTERNATIONAL SAE CONSORTIOUM, LTD 2013 - 2016
  • Long-Term Renal Outcomes after Acute Kidney Injury in Very-Low-Birth-Weight Infants  awarded by CHILDREN’S CENTER FOR RESEARCH AND INNOVATION 2009 - 2015
  • Acute Kidney Injury in Premature Infants "Role of Heme-Oxgenase 1"  awarded by American Society of Nephrology 2011 - 2014
  • International Pediatric Peritoneal Dialysis Network  awarded by CHILDREN'S MERCY HOSPITAL 2008 - 2013
  • Private Grant  awarded by F.Hoffmann-La Roche Ltd. 2010 - 2012
  • Viral Triggers of Alloimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University 2010 - 2012
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON) 2010 - 2012
  • Focal Segmental Glomerulosclerosis Clinical Trial Cohort  awarded by FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH 2010 - 2011
  • Acute Kidney Injury in the Premature Infant  awarded by National Kidney Foundation 2007 - 2010
  • Investigator On

  • Critical Translational Studies in Pediatric Nephrology  awarded by CHILDREN'S HOSPITAL MEDICAL CENTER (CINCINNATI) 2018 - 2022
  • Private Grant  awarded by Genentech 2018 - 2021
  • Private Grant  awarded by Sanofi US Services Inc 2017 - 2021
  • Chronic Kidney Disease in Children CKID IV  awarded by CHILDREN'S MERCY HOSPITAL 2018 - 2020
  • Private Grant  awarded by BAEBIES, INC. 2018 - 2019
  • The Child-Centered Outcomes in Practice and Research (COPR) Center of Excellence: Strengthing the Clinical Validity Evidence Base for PROMIS Measures in Chronically Ill Children  awarded by CHILDREN'S HOSPITAL (PHILADELPHIA) 2015 - 2019
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2014 - 2019
  • Private Grant  awarded by VIFOR 2016 - 2019
  • Cure Glomerulonephropathy (CureGN): Integrative Proteomics & Metabolomics for Pediatric Glomerula Disease Biomarkers  awarded by NATIONWIDE CHILDREN'S HOSPITAL 2015 - 2018
  • Private Grant  awarded by ROCKWELL MEDICAL, INC. 2015 - 2018
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2018
  • Chronic Kidney Disease in Children (CKiD III)  awarded by CHILDREN'S MERCY HOSPITAL 2013 - 2018
  • Private Grant  awarded by BRISTOL MYERS SQUIBB PHARMACEUTICAL COMPANY 2013 - 2018
  • Private Grant  awarded by RETROPHIN, INC. 2014 - 2017
  • International Pediatric Peritoneal Biopsy Study in Children  awarded by UNIVERSITY OF HEIDELBERG 2015 - 2016
  • Private Grant  awarded by ALEXION PHARMACEUTICALS, INC. 2014 - 2016
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2013 - 2015
  • Private Grant  awarded by NOVARTIS PHARMACEUTICALS CORPORATION 2014 - 2015
  • Private Grant  awarded by ABBVIE INC 2013 - 2015
  • Gene Therapy for Diamond Black Fan Anemia Using Induced Pluripotent Stem Cell Technology  awarded by KAUL PEDIATRIC RESEARCH INSTITUTE 2011 - 2015
  • Private Grant  awarded by AMGEN, INC. 2010 - 2014
  • Toward a Cure for DBA: Creation of Patient-Specific Gene Corrected Hematopoietic Stem Cells Using Inducible Pluriopotent Stem Cell Technology  awarded by DIAMOND BLACKFAN ANEMIA FOUNDATION, INC. 2012 - 2014
  • Chronic Kidney Disease in Children  awarded by CHILDREN'S MERCY HOSPITAL 2010 - 2013
  • Viral Triggers of Alioimmunity and Autoimmunity in Pediatric Lung Transplantation  awarded by Washington University 2012 - 2013
  • Randomized Intervention for Children with Vesicoureteral Reflux  awarded by Wayne State University 2010 - 2013
  • Novel Therapies for Chronic Allograft Dysfunction in Children  awarded by CHILDREN'S HOSPITAL (BOSTON) 2012 - 2013
  • Education And Training

  • Doctor of Medicine in Pediatrics Residency Program, University of Texas System : Medical Branch 1998
  • University of Texas Medical Branch, Internship 1999
  • Austin Pediatric Education Program, Residency 2002
  • Baylor College of Medicine, Postdoctoral Fellowship 2005
  • Full Name

  • David Askenazi